Nu-Med Plus, Inc.
Data quality: 83%
NUMD
OTC
Manufacturing
Measuring & Analyzing Instruments
$0.01
$0.00
(0.00%)
Mkt Cap: 1.09 M
Price
$0.01
Mkt Cap
1.09 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Negative free cash flow of -4,433.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.03
Interest Coverage-12.63
Valuation
PE (TTM)
-15.89
Below sector avg (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1385 peers)
Peer Comparison
vs Manufacturing sector median (1385 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -15.9 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -54.0 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
No forward estimates available
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -68,345.0 |
| ROE | N/A | ROA | -862.02% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -4,433.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.03 |
| Interest Coverage | -12.63 | Asset Turnover | N/A |
| Working Capital | -204,541 | Tangible Book Value | -204,541 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -15.89 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0.41% | ||
| Market Cap | 1.09 M | Enterprise Value | 1.09 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.00 | Revenue / Share | N/A |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 6.49% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 0.0 |
| Net Income | -68,345.0 | -125,526.0 | -130,167.0 | -830,061.0 | -2.01 M |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | -0.01 | -0.04 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -63,331.0 | -120,526.0 | -182,167.0 | -839,445.0 | -1.99 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | 2,267.0 | 2,267.0 | 9,365.0 | 11,794.0 |
| Interest Expense | 5,014.0 | -5,000.0 | 1,000.0 | 14,322.0 | 14,322.0 |
| Income Tax | — | — | — | — | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 9,373.0 | 13,456.0 | 79,545.0 | 22,163.0 | 557,135.0 |
| Total Liabilities | 224,469.0 | 160,207.0 | 142,570.0 | 154,521.0 | 89,432.0 |
| Shareholders' Equity | -215,096.0 | -146,751.0 | -63,025.0 | -132,358.0 | 467,703.0 |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 2,373.0 | — | — | 188,506.0 | 188,506.0 |
| Current Assets | 9,373.0 | 13,456.0 | 79,545.0 | 11,675.0 | 537,523.0 |
| Current Liabilities | 224,469.0 | 160,207.0 | 142,570.0 | 154,521.0 | 80,048.0 |
{"event":"ticker_viewed","properties":{"ticker":"NUMD","listing_kind":"stock","pathname":"/stocks/numd","exchange":"OTC","country":"US"}}